BioCentury
ARTICLE | Company News

Bayer sales and marketing update

May 19, 2008 7:00 AM UTC

Bayer notified FDA of plans to withdraw all remaining supplies of Trasylol aprotinin from hospital pharmacies and warehouses following publication of data from the Canadian BART trial in The New Engl...